Stockscreener 앱 받기
42.44
6.90%
2.74
전일 마감가:
$39.70
열려 있는:
$40.03
하루 거래량:
580.05K
Relative Volume:
1.04
시가총액:
$1.51B
수익:
$154.15M
순이익/손실:
$-33.58M
주가수익비율:
-75.79
EPS:
-0.56
순현금흐름:
$-20.74M
1주 성능:
-18.07%
1개월 성능:
-26.17%
6개월 성능:
+152.77%
1년 성능:
+348.63%
1일 변동 폭
$39.85
$42.52
1주일 범위
$37.00
$46.33
52주 변동 폭
$8.7202
$59.23
Harrow Inc Stock (HROW) Company Profile
명칭
Harrow Inc
전화
615.733.4731
주소
102 WOODMONT BLVD, NASHVILLE, CA
HROW을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| HROW | 42.44 | 1.51B | 154.15M | -33.58M | -20.74M | -0.56 |
| ZTS | 175.67 | 78.47B | 9.15B | 2.43B | 2.31B | 4.92 |
| HLN | 9.48 | 42.84B | 14.26B | 1.55B | 0 | 0.3327 |
| TAK | 13.29 | 42.13B | 30.27B | 1.93B | 3.45B | 0.444 |
| TEVA | 17.03 | 19.19B | 16.77B | -959.00M | 1.37B | -2.00 |
| VTRS | 13.13 | 15.67B | 15.24B | -646.50M | 1.88B | 1.53 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-09-08 | 재개 | B. Riley Securities | Buy |
| 2021-10-14 | 재개 | B. Riley Securities | Buy |
| 2021-09-24 | 개시 | Aegis Capital | Buy |
| 2021-07-02 | 개시 | Ladenburg Thalmann | Buy |
Harrow Inc 주식(HROW)의 최신 뉴스
HROW (Harrow) Total Inventories : $10.2 Mil (As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Cash Flow for Dividends : $0.0 Mil (TTM As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Long-Term Debt & Capital Lease Obligation : $195.6 Mil (As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Cash Flow from Operations : $4.3 Mil (TTM As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Operating Cash Flow per Share : $0.12 (TTM As of Sep. 2024) - GuruFocus.com
HROW (Harrow) PE Ratio without NRI : At Loss (As of Nov. 20, 2024) - GuruFocus.com
HROW (Harrow) Total Assets : $351.5 Mil (As of Sep. 2024) - GuruFocus.com
First Turn Management LLC Purchases New Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
28,177 Shares in Harrow, Inc. (NASDAQ:HROW) Purchased by Oppenheimer & Co. Inc. - MarketBeat
Harrow, Inc. (NASDAQ:HROW) Stock Position Lessened by Royce & Associates LP - MarketBeat
Harrow Stock: Spotlight On IHEEZO (NASDAQ:HROW) - Seeking Alpha
Harrow (NASDAQ:HROW) Shares Down 7.3%Here's Why - MarketBeat
Harrow Announces Participation in Upcoming Investor Conferences - BioSpace
Harrow Health, Inc. (NASDAQ:HROW) Q3 2024 Earnings Call Transcript - Insider Monkey
Harrow to Present at Major Healthcare Conferences, Including Piper Sandler's Annual Event | HROW Stock News - StockTitan
Harrow Inc (HROW) Q3 2024 Earnings Call Highlights: Record Reven - GuruFocus.com
Harrow Inc (HROW) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... By GuruFocus - Investing.com Canada
Harrow Inc (HROW) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... - Yahoo Finance
Harrow Inc Com (HROW) Quarterly 10-Q Report - Quartzy
Harrow Grows Revenue 44 Percent in 2024 Third Quarter, Confirms Full-Year Guidance - Vision Monday
Harrow Inc. Reports Strong Q3 2024 Growth - TipRanks
Harrow (NASDAQ:HROW) Shares Gap DownWhat's Next? - MarketBeat
Advance Auto Parts Posts Weak Results, Joins Harrow, Taysha Gene Therapies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
Q3 2024 Harrow Inc Earnings Call Transcript - GuruFocus.com
Harrow Inc (HROW) Q3 2024 Earnings: Revenue at $49.3M, Misses Es - GuruFocus.com
Los Angeles Capital Management LLC Sells 38,168 Shares of Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Harrow: Q3 Earnings Snapshot - New Haven Register
Harrow, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Harrow stock plunges 20% on weaker-than-expected Q3 earnings - MSN
Harrow stock plunges 20% on weaker-than-expected Q3 earnings (NASDAQ:HROW) - Seeking Alpha
Harrow (HROW) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance
HROWHarrow, Inc. Latest Stock News & Market Updates - StockTitan
Harrow Q3 Revenue Surges 44% to $49.3M as VEVYE Prescriptions Jump 55% | HROW Stock News - StockTitan
Harrow Inc (HROW) Shares Up 6.99% on Nov 13 - GuruFocus.com
Harrow Inc (HROW) Q3 2024 Earnings Report Preview: What To Look For - GuruFocus.com
Harrow Partners with GoodRx, Cuts Prices on Key Eye Drug Portfolio | HROW Stock News - StockTitan
Harrow secures Medicare coverage for dry eye treatment VEVYE By Investing.com - Investing.com Canada
Harrow Inc (HROW) Stock Price Down 3.18% on Nov 12 - GuruFocus.com
Earnings Outlook For Harrow - Benzinga
Harrow secures Medicare coverage for dry eye treatment VEVYE - Investing.com India
Harrow Announces Market Access Wins for VEVYE® - Business Wire
Harrow's VEVYE Secures Major Medicare Coverage, Reaching 25M+ Beneficiaries in 2025 | HROW Stock News - StockTitan
Harrow: VEVYE And Its Impact On The DED Market (NASDAQ:HROW) - Seeking Alpha
Equitable Trust Co. Has $2.62 Million Stock Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Harrow (HROW) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance
Woodmont Investment Counsel LLC Decreases Holdings in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Harrow Partners with Asembia to Enhance Provider and Patient Experience Through Nationwide Digital Services and Hub Support for Harrow’s Branded Eyecare Products - Business Wire
Best Momentum Stocks To Buy For November 6th - Barchart
Will Harrow (HROW) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance
Harrow (HROW) Scheduled to Post Quarterly Earnings on Wednesday - MarketBeat
Imprimis Pharmaceuticals, Inc. announced that it has received $3 million in funding from Immy Funding LLC. - Marketscreener.com
Harrow Inc (HROW) 재무 분석
매출
순이익
현금흐름
주당 순 이익
8.84%
자본화:
|
볼륨(24시간):